" class="no-js "lang="en-US"> Healx - Medtech Alert
Wednesday, March 27, 2024
Healx | Pharmtech Focus

Healx

About Healx

Healx

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments.

Our AI drug discovery platform leverages public and proprietary biomedical data and features the world’s leading knowledge graph for rare diseases.

Combining this technology with patient insights and drug discovery expertise, our mission is to advance 100 rare disease treatments towards the clinic by 2025.

Related Story

Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park

July 13 2022

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]

Healx and Ovid Therapeutics Enter Strategic Partnership

February 9 2022

Ovid Therapeutics (NASDAQ:OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of […]

Healx Receives IND and Orphan Drug Designation for Fragile X Clinical Trial

October 20 2021

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, is proud […]

Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd.

August 6 2021

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced […]

Healx Using Artificial Intelligence to Find Combination Drug Treatments for Covid-19

April 6 2021

Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its […]